Background {#s1}
==========

Klebsiella pneumoniae is a non-motile, gram-negative bacterium, which inhabits in diverse ecological niches ranging from soil to water and plants, and it is also opportunistic pathogen causing hospital-acquired disease in patients with the compromised immune system \[[@R01]\]. Human clinical isolates are considered as indistinguishable from environmental isolates with respect to their biochemical reactions and other attributes \[[@R02]\]. In plants, K. pneumoniae strains had been reported to fix nitrogen and promote growth of the plants \[[@R03]\]. Rajkumari et al. \[[@R04]\] had reported that Klebsiella strains have the ability to degrade hydrocarbons, including polyaromatic hydrocarbons (PAH). Previously, Holt et al. \[[@R05]\], have determined the diversity of genetic variation in specific genes associated with virulence and antibiotic resistance to track the emergence of invasive K. pneumoniae infections.

The advent of whole-genome sequencing along with reliable bioinformatics workflow has made possible to study the distinct genome patterns that may reflect the variation due to evolutionary pressures. Identification of conserved genomic core genes and pan genes from a collection of bacterial genomes depends on classifying orthologous genes based on similar sequences \[[@R06]\]. It provides valuable information and deeper insights into bacterial genome evolution, genes associated with host adaptation, virulence, and pathogenesis \[[@R07]\]. In previous work, the whole genome sequence analysis of clinical and environmental K. pneumoniae suggested that they are closely related but antibiotic resistance and virulence factors were more frequent in clinical isolates. In fact, the phylogenomics analysis of K. pneumoniae whole genome failed to result in any distinct segregation of clinical and non-clinical clades of K. pneumoniae, as the genomes originating from either group were mixed throughout the tree \[[@R08]\].

Therefore, in this work, a genome analysis workflow was designed and used to identify the genes and their functions, which can be considered to resolve between clinical and non-clinical K. pneumoniae isolates ([Figure 1](#F1){ref-type="fig"}). We used phylogenomics approach followed by the comparison of K. pneumoniae codon usage bias (CUB) pattern across the genes. In fact, the synonymous codons are known to be used non-randomly, and this unequal usage of the synonymous codon is called codon usage bias \[[@R09]\]. It is of interest to describe the distinctive features gleaned from the comparative genome analysis of clinical and non-clinical isolates of K. pneumoniae.

Methodology: {#s2}
============

Genome comparison and Sequence Data {#s2a}
-----------------------------------

Comparative genome analysis of a collection of K. pneumoniae (clinical and non-clinical genomes) was examined. A private project was created with standard K. pneumoniae genomes, comprising of non-clinical/environmental and clinical isolates. Phylogenetic relationships between thirty-eight K. Pneumoniae genomes were analyzed using EDGAR software platform (v.2.3) (http://edgar.computational.bio). EDGAR allows the calculation and identification of the core-pan genomes between different genomes. The nucleotide coding sequence (CDS) for eighty-eight genes, (24 drug resistant (DRGs), 16 infections related genes (IRGs) and 48 xenobiotic metabolism genes (XMGs) of five clinical and five non-clinical K. pneumoniae genomes having perfect start and stop codon were retrieved from IMG database (http://img.jgi.doe.gov) and gene details are given below.

The effective number of codons {#s2b}
------------------------------

The observed effective number of codons (ENC) for each coding sequence of gene sets of K. pneumoniae was calculated using the formula given by Wright \[[@R10]\]. ENC value shows an inverse relationship with the degree of codon bias. ENC values range from 20 to 61, where low ENC value (\<35) indicates high codon usage bias and high ENC value indicates low codon usage bias \[[@R10]\].

ENC = 2+9//F~2~+1//F~3~+5//F~4~+3//F~6~

where FK (K= 2, 3, 4, 6) is the mean of FK values for the K -fold degenerate amino acids.

Nucleotide composition analysis {#s2c}
-------------------------------

The overall nucleotide composition (A%, C%, T% and G%) and occurrence of overall frequency of the nucleotide (G+C) at first (GC1), second (GC2) and third (GC3) position of the synonymous codons were calculated in the coding sequences of the genes to quantify the extent of base compositional bias. The calculations were done using a Perl script developed by one of the authors (SC).

Neutrality plot {#s2d}
---------------

The neutrality plot is a scattered plot, which is used to determine the role of directional mutational pressure against selection pressure during evolution. It is the regression of GC12 on GC3, as the synonymous mutation occurs in the 3^rd^ position of codon while non-synonymous mutations occur in the 1^st^ and 2^nd^ position. The non-synonymous mutation transforms the activity of the gene, which resulted from the alteration of amino acid sequence. In neutrality plot, if the regression line falls near the diagonal, it signifies weak external selection pressure and the role of mutation pressure is dominant.

Software and Statistical Analysis {#s2e}
---------------------------------

Heat map of the specific clinical and non-clinical genes was generated by Expression Heatmapper using an average linkage method with Euclidean distance \[[@R11]\]. A network of genes was created for selected unique genes of clinical and non-clinical isolates by Cytoscape 3.4.0 with GeneMANIA plugin. The node degree distribution of the complex protein-protein interaction network was obtained from Cytoscape by Network analyzer \[[@R12]\]. A PERL program was developed to estimate the genetic codon usage bias indices and the selection pressure on the coding sequence of K. pneumoniae genes. Correlation analysis was performed to identify the degree of relationship between two parameters by Karl Pearson\'s method. The significance of the correlation coefficient was tested by t-test for (n-2) degrees of freedom at p\<0.01 or p\<0.05. Statistical analyses were performed using IBM SPSS version 21.0 for windows.

Results {#s3}
=======

Phylogenomic relationship of K. pneumoniae (clinical and non-clinical) genomes was examined from the deduced amino acid sequences of the core genomes and resolved the close relationship among non-clinical and clinical isolates. The main features of the genome sequences of K. pneumoniae non-clinical strain and clinical strain are summarized below ([Table 1](#T1){ref-type="table"}). The tree was built out of core genome taking 3568 genes per genome, 135584 in total. There was no clear separation of clades between clinical and non-clinical isolates ([Figure 2](#F2){ref-type="fig"}). Phylogenomic analysis of the core genomes 48 clinical and 29 environmental K. pneumoniae isolates had demonstrated that the isolates were intermixed and failed to result in any distinct segregation of clinical and non-clinical clades of K. pneumoniae \[[@R08]\].

Based on the phylogenomics results, genomes (clinical and non-clinical) were selected for further analysis and orthologous genes in K. pneumoniae were calculated. Core genome analyses of the K. pneumoniae genomes showed that it consisted of 3568 conserved genes. While the pan-genome appeared to grow rapidly and the core genome was limited to less than 4000 genes. There are several Pan-genome analysis pipelines are available \[[@R13],[@R14],[@R15], [@R16]\] however we have used EDGAR pipeline for studying genetic variation, and function enrichment analyses of the gene clusters. Core versus pan-genome development analysis of K. pneumoniae genomes revealed that 3568 formed the core genome while 11780 genes formed the pan-genome when K. pneumoniae AWD5 is used as the reference genome ([Figure 3](#F3){ref-type="fig"}). The genes in AWD5 strain cover 89.45% of the coding genes in the genome. Average nucleic acid identities (ANI) of AWD5 with K. pneumoniae KP-1, K. pneumoniae ATCC-BAA 2146 and K. pneumoniae subsp. pneumoniae NTUH-K2044 revealed 99% sequence homologies and 94.02% with K. pneumoniae 342. The genomes of AWD5 and ATCC BAA-2146 (clinical strain) appear to be most similar by sharing 4529 orthologs whereas 4442 orthologs were found between AWD5 and the environment isolate KP-1. Pan-genome of six K. pneumoniae strains was reported to be consisted of 4,829 core genes, such a high percentage signifies a high rate of conservation among the strains. Previously, some studies had reported that phenotypic and genetic features of K. pneumoniae of environmental and clinical origin were similar and therefore, the isolates cannot be distinguished \[[@R02], [@R17]\].

Gene content analysis of K. pneumoniae {#s3a}
======================================

By investigating the presence and absence of genes in K. pneumoniae, most of the regions within the genomes were found to be conserved, including the virulence genes present in the clinical strains regardless of disease source. The orthologs include components of regulatory pathways such as basic transcriptional machinery, DNA relication, homologous recombination, mismatch repair, nucleotide excision repair, bacterial secretion system and protein export. Genes attributable to the production of indole-3-acetic acid (IAA) (ipdC), solubilization of phosphate (pqqABCDEF, phn and pho gene clusters, pstBACS), synthesis of siderophore (ent, fep gene clusters), acetoin and 2,3-butanediol (alsDSR, budC) are found to be conserved. It also revealed the presence of multicomponent nitrate or nitrite transport system. More than 13 genes involved in benzoate (ben genes), catechol (cat genes), protocatechuate (pca genes) were conserved in the core genome of K. pneumoniae.

Further, to obtain the unique genes, the genomes were segregated into two groups i.e., clinical and non-clinical, taking five genomes for each group and analyzed separately. In clinical isolates, such core genes included virulence factor capsule assembly protein, multidrug transporter subunit (mdtABCD), type II toxin-antitoxin systems, and type VI secretion system (TVISS). TVISS were found to be shared among clinical and non-clinical isolates however, at least eight CDSs determined in clinical genomes involved in TVISS, were not found in non-clinical isolates. It has been reported that an environmental isolate Kp342 and clinical isolate MGH78578 seemed to share core components of TVISS \[[@R18]\]. The unique core genome of non-clinical isolate consisted of aromatic compound degrading genes catB, benA and several transporters including genes for citrate utilization. This was in agreement to the hypothesis that environmental isolates are more versatile for their catabolic processes, as the ability to degrade organic compounds govern the evolution of novel catabolic abilities of bacteria that can survive in different habitats \[[@R19]\]. We took the presence/absence of such individual genes as the categorical analyst parameter subjected to build a phylogenetic tree. And showed that the strains from similar clinical and environmental sources were not linked than those from different sources ([Figure 4](#F4){ref-type="fig"}). The core genes discriminated the clinical and environmental genomes and accessory genes segregated the strains within the group. Based on the gene functions, several gene sets were experimented which may resolve clinical and non-clinical isolates. Accordingly, one set of unique core genes in non-clinical isolates and clinical isolates is given in the figure 4 on the basis of which genomes were resolved into two distinct categories, further few genes were useful for resolving the genomes within the particular group. Virulence factor (galF, wcaI, wcaG, wzb, wzc, manBC), allantoin utilization genes (gcl, allABCDS, ybbW), TVISS (impL, vgrG, tssFGJ) and other antibiotic resistance genes were also observed as accessory genes in ten K. pneumoniae. The clinical genomes possessed multidrug resistance gene blaCTX-M-15 as accessory gene; this is an indication of horizontal gene transfer that might have occurred between virulent and multidrug-resistant K. pneumoniae strains \[[@R20]\]. This finding agrees with the previous study, which reported that resistance to multiple antibiotics was found to be more frequent in clinical origin than that of environmental origin \[[@R21]\]. The gene interaction network of specific core genes of clinical and non-clinical K. pneumoniae genomes was analyzed in cytoscape and GeneMANIA ([Figure 5](#F5){ref-type="fig"}) and data is given in supplementary file. It was noted that the functional partners were not part of the core genome of the respective group; however, it surely had interactions, and hence influence the functions of these genes.

Extent of Codon usage variation in K. pneumoniae {#s3b}
================================================

In order to analyze codon usage variation five K. pneumoniae genomes were selected considering their level of similarity. The data set was restricted to 5 genomes to avoid non-ambiguity. According to the EDGAR interface, genes were placed at intersections of the Venn diagram only if they were reciprocal matches. The analysis utilizes all CDS of the genomes and it is not restricted to the core genome. Among the K. pneumoniae strains, AWD5 chromosome shared 31 orthologous CDS with BA2146 and further 188 CDS conjointly with the strain KP-1. Moreover, 65 orthologous CDS are found to be shared conjointly by environmental isolates AWD5, KP-1 and Kp342 ([Figure 6](#F6){ref-type="fig"}). Also, it indicated that AWD5 has 10 singleton genes. Besides, the singletons that resemble to the genes without reciprocal best hit to another genome, as orthologs does not necessarily have to be a proper singleton.

The codon usage variation was studied for eighty-eight genes (24 DRGs, 16 IRGs, and 48 XMGs) from five K. pneumoniae genomes of non-clinical origin (Kp342, KP-1, AWD5) and clinical origin (NK2044, BA2146) core genome. Selected genes details are given in the supplementary file ([Table 2](#T2){ref-type="table"}).

To quantify the extent of variation in codon usage among different genomes of K. pneumoniae, the effective number of codon (ENC) values for three gene sets of each genome was calculated. The ENC is a non-directional measure of codon usage bias, widely used to measure for individual genes. The ENC values among five K. pneumoniae strains ranged from 37.1 to 39.71, indicating low codon usage bias ([Table 3](#T3){ref-type="table"}) for IRGs, DRGs and XMGs respectively. (ENC \< 40) represents stable ENC values and indicates that there is almost no variation of codon usage bias among the genes of K. pneumoniae. It also indicates conserved genomic composition among different K. pneumoniae genomes. Correlation analysis between codon usage bias and compositional properties of GC content were analyzed to understand the effect of base composition on codon usage bias. Negative correlation was observed between ENC and GC composition ([Table 4](#T4){ref-type="table"}). These results suggested that natural selection might have played an important role in codon usage pattern across the genes. Our results show that codon usage bias and gene expression among different K. pneumoniae genomes was lower, slightly biased in the genes \[[@R22]\].

Nucleotide composition analyses of coding sequences of IRGs, DRGs, and XMGs ([Table 3](#T3){ref-type="table"}) showed mean percentage of GC and AT compositions was 59.44% and 40.5% in IRGs, 59.36% and 40.66% in DRGs and 61.66% and 38.34% in XMGs respectively. Genes were GC-rich, GC content at the third position was higher than at the first and second codon position and the greatest difference of GC content was found between the second and the third codon positions. Hence, the overall nucleotide composition suggested that the nucleotide C and G occurred more frequently compared to A and T in the coding sequences and it is expected that G/C-ended codons might be preferred over A/T ended codons in the genomes. The difference in frequencies of A and T and to that of G and C were not the same which indicates that natural selection might have played a role in codon usage pattern \[[@R22]\].

A neutrality plot analysis of GC12 (average value of GC1 and GC2) versus GC3 ([Figure 7](#F7){ref-type="fig"}) was drawn to characterize the correlation of the three codon position of GC [@R23]\], and to estimate the influence of selection and mutation pressure on codon usage bias of IRGs, DRGs and XMGs of five K. pneumoniae strains \[[@R24]\]. The regression coefficient of GC12 on GC3 for IRGs of the K. pneumoniae strains AWD5, BA2146, KP-1, Kp342 and NK2044 were 0.0133, 0.0701, 0.0249, 0.0033 and 0.0099 indicating relative neutrality of 1.33%, 7.01%, 2.49%, 0.33%, and 0.99% respectively. The GC12 was influenced by mutation pressure and natural selection with a ratio of 1.33/98.67=0.014, 7.01/92.99=0.75, 2.49/97.51=0.026, 0.33/99.67=0.003, and 0.99/99.01=0.009 for AWD5, BA2146, KP-1, Kp342 and NK2044 respectively. The subsequent correlation analysis revealed positive correlation between GC12 and GC3 in DRGs and XMGs ([Table 5](#T5){ref-type="table"}). These results suggest that natural selection played a major role while mutation pressure played minor role in shaping the composition of coding sequence of K. pneumoniae \[[@R25]\].

Conclusions: {#s4}
============

A comparative genome analysis shows that clinical and non-clinical strains of K. pneumonia are similar and are not separated by phylogeny. However, gene level comparison help distinguish these isolates where mdtABCD, toxin-antitoxin systems are distinctive to clinical isolates and catB, benA, transporter genes for citrate utilization are limited to non-clinical isolates. Thus, these data help distinguish clinical and non-clinical isolates of K. pneumoniae towards the understanding of genome diversity during speciation.
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###### Genomic features and comparison of K. pneumoniae genomes used for analysis

  Strain                                              Size (bp)   CDS     GC (%)   Source         References
  --------------------------------------------------- ----------- ------- -------- -------------- -----------------------
  K. pneumoniae AWD5 (AWD5)                           4807409     4636    58.18%   Non-clinical   Rajkumari et al. 2017
  K. pneumoniae 342 (Kp342)                           5641239     5768    56.87%   Non-clinical   Fouts et al. 2008
  K. pneumoniae SKGH01 (SKGH01)                       6088457     5777    56.54%   Clinical       Alfaresi 2018
  K. pneumoniae subsp. pneumonia PittNDM01 (PNDM01)   5812304     5529    56.78%   Clinical       Doi et al. 2014
  K. pneumoniae J1 (J1)                               5406866     5039    57.24    Non-clinical   Pang et al. 2016
  K. pneumoniae strain KCTC-2242 (KCT242)             5462423     5152    57.28    Non-clinical   Shin et al. 2012
  K. pneumoniae subsp. pneumonia RJF293 (RJF293)      5450593     5077    57.2     Clinical       Wang et al. 2018
  K. pneumoniae strain KP-1(KP-1)                     5131085     4755    57.6     Non-clinical   Lee et al. 2013
  K. pneumoniae NTUH-K2044 (NK2044)                   5248520     5,006   57.7     Clinical       Wu et al. 2009
  K. pneumoniae ATCC BAA- 2146 (BA2146)               5680367     5552    56.9     Clinical       Hudson et al. 2014
  K. pneumoniae subsp. pneumoniae KPNIH10             5395263     5653    57.14    clinical       NZ_CP007727
  K. pneumoniae subsp. pneumoniae KPNIH1              5394056     5654    57.14    clinical       NZ_CP008827
  K. pneumoniae subsp. pneumoniae strain KPNIH33      5574202     5500    57.21    clinical       NZ_CP009771
  K. pneumoniae subsp. pneumoniae KPNIH27             5241638     5932    56.71    clinical       NZ_CP007731
  K. pneumoniae subsp. pneumoniae KPNIH24             536164      5590    57.12    clinical       NZ_CP008797
  K. pneumoniae subsp. pneumoniae KPNIH30             5306618     5346    57.26    clinical       NZ_CP009872
  K. pneumoniae strain XH209                          5118878     4881    57.63    clinical       NZ_CP009461
  K. pneumoniae strain CAV1016                        5387681     5391    57.22    clinical       NZ_CP017934
  K. pneumoniae strain CAV1042                        5424949     5500    56.81    clinical       NZ_CP018671
  K. pneumoniae strain CAV1596                        5402147     5450    57.14    clinical       NZ_CP011647
  K. pneumoniae strain CAV1417                        5208900     5,373   56.98    clinical       NZ_CP018352
  K. pneumoniae Kp_Goe_71070                          5497083     5434    56.95    clinical       NZ_CP018450
  K. pneumoniae Kp_Goe_827026                         5373056     5662    56.62    clinical       NZ_CP018707
  K. pneumoniae Kp_Goe_149473                         5373056     5677    56.62    clinical       NZ_CP018686
  K. pneumoniae Kp_Goe_152021                         5373055     5673    56.62    clinical       NZ_CP018713
  K. pneumoniae Kp_Goe_828304                         5373056     5683    56.62    clinical       NZ_CP018719
  K. pneumoniae MNCRE78                               5454003     5584    56.86    clinical       NZ_CP018428
  K. pneumoniae MNCRE53                               5490693     5627    56.87    clinical       NZ_CP018437
  K. pneumoniae Kp_Goe_154414                         5159815     5618    56.62    clinical       NZ_CP018337
  K. pneumoniae Kp_Goe_62629                          5423372     5607    57.16    clinical       NZ_CP018364
  K. pneumoniae Kp_Goe_33208                          5497872     5429    56.96    clinical       NZ_CP018447
  K. pneumoniae Kp_Goe_822917                         5294741     5360    57.21    clinical       NZ_CP018438
  K. pneumoniae strain CR14                           5470889     5869    56.78    clinical       NZ_CP015392
  K. pneumoniae Kp_Goe_121641                         5478335     5390    56.96    clinical       NZ_CP018735
  K. pneumoniae subsp. pneumoniae KPR0928             5309305     5286    57.32    clinical       NZ_CP008831
  K. pneumoniae strain 34618                          5313576     5487    57.21    clinical       NZ_CP010392
  K. pneumoniae strain AR0049                         5435743     5661    56.98    clinical       NZ_CP018816
  K. pneumoniae strain K1                             5453585     5237    57.44    clinical       NZ_LOEJ01000001

###### Selected gene of K. pneumoniae and functions

  Sl.no   Gene        Protein function
  ------- ----------- ----------------------------------------------------------------------------------------------------------
  1       lepA        GTP-binding protein
  2       ureC        urease subunit alpha
  3       groL        chaperonin GroEL
  4       fimA        type 1 major fimbrial subunit precursor
  5       fimD        putative export and assembly usher protein of type 1 fimbriae
  6       fimG        type 1 fimbrial minor component
  7       fimH        type 1 fimbrial adhesin precursor
  8       cyaA        adenylate cyclase
  9       sdhA        succinate dehydrogenase subunit A
  10      tolC        outer membrane channel protein
  11      norW        nitric oxide reductase
  12      norV        anaerobic nitric oxide reductase flavorubredoxin
  13      RpoS        RNA polymerase, sigma 38 subunit
  14      RpoN/SigL   RNA polymerase, sigma 54 subunit
  15      yegQ        putative protease
  16      LuxS        S-ribosylhomocysteine lyase/quorum-sensing autoinducer 2 (AI-2) synthesis protein
  17      arnA        UDP-4-amino-4-deoxy-L-arabinose formyltransferase
  18      arnB        UDP-4-amino-4-deoxy-L-arabinose-oxoglutarate aminotransferase
  19      arnC        undecaprenyl-phosphate 4-deoxy-4-formamido-L-arabinose transferase
  20      arnF        undecaprenyl phosphate-alpha-L-ara4N flippase subunit
  21      arnT        4-amino-4-deoxy-L-arabinose transferase
  22      amiA        N-acetylmuramoyl-L-alanine amidase
  23      amiB        N-acetylmuramoyl-L-alanine amidase
  24      sapB        cationic peptide transport system permease protein
  25      sapC        cationic peptide transport system permease protein
  26      sapD        cationic peptide transport system ATP-binding protein
  27      sapF        cationic peptide transport system ATP-binding protein
  28      basS        two-component system, OmpR family, sensor histidine kinase
  29      mraY        Phospho-N-acetylmuramoyl-pentapeptide-transferase
  30      oppA        oligopeptide transport system substrate-binding protein
  31      oppB        oligopeptide transport system permease protein
  32      oppC        oligopeptide transport system permease protein
  33      oppD        oligopeptide transport system ATP-binding protein
  34      oppF        oligopeptide transport system ATP-binding protein
  35      ppiA        peptidyl-prolyl cis-trans isomerase A (cyclophilin A)
  36      phoP        two-component system, OmpR family, response regulator
  37      phoQ        two-component system, OmpR family, sensor histidine kinase
  38      ftsI        peptidoglycan synthetase
  39      dnaK        molecular chaperone
  40      marA        transcriptional regulator, AraC family
  41      benA/xylX   benzoate/toluate 1,2-dioxygenase alpha subunit,
  42      catA        catechol 1,2-dioxygenase
  43      catB        muconate cycloisomerase
  44      catC        muconolactone D-isomerase
  45      pcaB        3-carboxy-cis,cis-muconate cycloisomerase,
  46      pcaD        3-oxoadipate enol-lactonase
  47      pcaG        protocatechuate 3,4-dioxygenase alpha subunit,
  48      pcaH        protocatechuate 3,4-dioxygenase beta subunit,
  49      pcaI        3-oxoadipate CoA-transferase alpha subunit,
  50      pcaJ        3-oxoadipate CoA-transferase beta subunit,
  51      paaA        ring-1,2-phenylacetyl-CoA epoxidase subunit,
  52      paaF        enoyl-CoA hydratase
  53      paaH        3-hydroxybutyryl-CoA dehydrogenase,
  54      paaK        phenylacetate-CoA ligase
  55      paaZ        oxepin-CoA hydrolase / 3-oxo-5,6-dehydrosuberyl-CoA semialdehyde dehydrogenase,
  56      gabD        succinate semialdehyde dehydrogenase,
  57      gabT        4-aminobutyrate aminotransferase / (S)-3-amino-2-methylpropionate transaminase,
  58      glnB        nitrogen regulatory protein P-II family,
  59      Gst         glutathione S-transferase
  60      hpaA        AraC family transcriptional regulator, 4-hydroxyphenylacetate 3-monooxygenase operon regulatory protein,
  61      hpaC        4-hydroxyphenylacetate 3-monooxygenase reductase component,
  62      hpaD/hpcB   3,4-dihydroxyphenylacetate 2,3-dioxygenase,
  63      hpaF        5-carboxymethyl-2-hydroxymuconate delta isomerase,
  64      hpaH        2-oxohept-3-enedioate hydratase,
  65      hpaG        5-carboxy-2-oxohept-3-enedioate decarboxylase HpaG1 subunit
  66      hpaG        5-carboxy-2-oxohept-3-enedioate decarboxylase HpaG2 subunit
  67      mhpA        3-hydroxyphenylpropionate hydroxylase,
  68      mhpB        2,3-dihydroxyphenylpropionate 1,2-dioxygenase,
  69      mhpC        2-hydroxy-6-ketonona-2,4-dienedioate hydrolase,
  70      mhpD        2-keto-4-pentenoate hydratase
  71      mhpE        4-hydroxy 2-oxovalerate aldolase
  72      mhpF        acetaldehyde dehydrogenase
  73      entA        2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase,
  74      entB        bifunctional isochorismate lyase / aryl carrier protein,
  75      entC        isochorismate synthase
  76      entD        enterobactin synthetase component D,
  77      fepA        outer membrane receptor for ferrienterochelin and colicins,
  78      fepB        iron complex transport system substrate-binding protein,
  79      fepC        iron complex transport system ATP-binding protein,
  80      fepD        iron complex transport system permease protein,
  81      pqqB        pyrroloquinoline quinone biosynthesis protein B,
  82      pqqC        pyrroloquinoline-quinone synthase,
  83      pqqD        pyrroloquinoline quinone biosynthesis protein D,
  84      pqqE        pyrroloquinoline quinone biosynthesis protein E,
  85      pstA        phosphate ABC transporter membrane protein 2, PhoT family,
  86      pstB        phosphate ABC transporter ATP-binding protein, PhoT family,
  87      pstC        phosphate ABC transporter membrane protein 1, PhoT family,
  88      pstS        phosphate ABC transporter substrate-binding protein, PhoT family,

###### Nucleotide composition analysis in the coding sequence of gene sets in K. pneumoniae strains

  Sl. No.                                                                                         A                            T        G        C        AT%     GC%     GC1%    GC2%    GC3%    AT3%    GC12%   ENC
  ----------------------------------------------------------------------------------------------- ---------------------------- -------- -------- -------- ------- ------- ------- ------- ------- ------- ------- -------
  Infection-related gene                                                                                                                                                                                          
  AWD5                                                                                            313.1                        259.9    403.8    435.6    40.7    59.3    63.4    42.3    72.1    27.9    52.8    38.19
  KP-1                                                                                            308.8                        260.9    406.6    431.2    40.5    59.5    63.8    42.5    72.1    27.8    52.8    38.46
  Kp342                                                                                           299.7                        247.1    385.8    415.4    40.6    59.5    63.9    42.2    72.2    27.8    53.1    37.56
  BA2146                                                                                          296.3                        248.1    386.2    411.3    41      59      63.8    41.7    71.4    28.6    52.9    39.21
  NK2044                                                                                          297.2                        248.8    390.1    415.4    40.5    59.5    63.8    42.5    72.2    27.7    53.2    38.64
  Mean                                                                                            303.02                       252.96   394.5    421.78   40.66   59.36   63.74   42.24   72      27.96   52.96   38.91
  SD                                                                                              7.501                        6.827    9.96     10.85    0.207   0.219   0.195   0.328   0.339   0.365   0.182   0.61
  Drug resistance gene                                                                                                                                                                                            
  AWD5                                                                                            214.8                        210.8    302.3    323.2    40.4    59.5    64.4    40.6    73.5    26.4    52.6    39.23
  KP-1                                                                                            213.4                        211      302.5    321.2    40.5    59.5    64.5    40.7    73.3    26.6    62.9    39.17
  Kp342                                                                                           220.5                        218.2    310      325.5    40.7    59.3    64.3    40.9    72.6    27.3    62.6    39.71
  BA2146                                                                                          214.9                        212.9    301.6    319.7    40.6    59.3    64.3    40.8    72.9    27.1    62.7    39.5
  NK2044                                                                                          213.9                        211      303.4    322.1    40.3    59.6    64.6    40.7    73.5    26.5    63.1    39.3
  Mean                                                                                            215.5                        212.78   303.96   322.34   40.5    59.44   64.42   40.74   73.16   26.78   60.78   39.38
                                                                                                  Xenobiotic metabolism gene                                                                                      
  SD                                                                                              2.864                        3.148    3.437    2.182    0.158   0.134   0.131   0.114   0.397   0.396   4.577   0.22
                                                                                                                                                                                                                  
  AWD5                                                                                            183.5                        168.7    285.3    296.6    38.3    61.7    67.1    43.4    74.6    25.3    55.3    38.93
  KP-1                                                                                            178.2                        161.3    271.7    285.7    38.3    61.7    67.1    43.5    74.5    25.4    55.3    39.1
  Kp342                                                                                           179.1                        162.8    270.6    284.2    38.5    61.5    66.9    43.5    73.8    26.1    55.2    39.36
  BA2146                                                                                          178.3                        160.8    271.6    285.3    38.3    61.7    67.1    43.5    74.5    25.5    55.2    37.1
  NK2044                                                                                          177.8                        160.6    271.3    284.8    38.3    61.7    67.1    43.4    74.4    25.6    55.3    38.19
  Mean                                                                                            179.38                       162.84   274.1    287.32   38.34   61.66   67.06   43.46   74.36   25.58   55.26   38.52
  SD                                                                                              2.351                        3.387    6.276    5.218    0.089   0.089   0.089   0.055   0.321   0.311   0.054   0.91
  SD: standard deviation, GC12: the average of GC contents at first and second codon positions.                                                                                                                   

###### Summary of correlation analysis between ENC and various GC content

  ENC                           GC           GC1          GC2      GC3
  ----------------------------- ------------ ------------ -------- ------------
  AWD5 r                        -0.414\*     -0.443\*     -0.184   -0.245
  p value                       0.044        0.03         0.388    
                                                                   0.249
  KP-1 r                        -0.440\*     -0.440\*     -0.212   -0.265
  p value                       0.031        0.032        0.319    0.211
  KP342 r                       -0.386       -0.511\*\*   0.148    -0.298
  p value                       0.057        0.009        0.481    0.148
  BA2146 r                      -0.466\*     -0.474\*     -0.079   -0.356
  p value                       0.022        0.019        0.715    0.087
  NK2044 r                      -0.441\*     -0.450\*     -0.228   -0.265
  p value                       0.031        0.027        0.284    0.211
                                                                   
  ENC                           GC           GC1          GC2      GC3
  AWD5 r                        -0.275       -0.426       0.206    -0.155
  p value                       0.302        0.1          0.444    0.566
  KP-1 r                        0.047        -0.312       0.311    0.017
  p value                       0.863        0.239        0.24     0.949
  KP342 r                       0.042        -0.208       0.014    0.184
  p value                       0.877        0.439        0.958    0.496
  BA2146 r                      -0.527\*     -0.520\*     0.127    -0.437
  p value                       0.036        0.039        0.639    0.091
  NK2044 r                      -0.028       -0.359       0.32     -0.063
  p value                       0.918        0.171        0.227    0.817
                                                                   
  ENC                           GC           GC1          GC2      GC3
  AWD5 r                        -0.348\*     0.026        -0.22    -0.503\*\*
  p value                       0.015        0.86         0.133    0
  KP-1 r                        -0.369\*\*   -0.01        -0.194   -0.516\*\*
  p value                       0.01         0.947        0.186    0
  KP342 r                       -0.384\*\*   0.056        -0.203   -0.580\*\*
  p value                       0.007        0.708        0.167    0
  BA2146 r                      -0.395\*\*   -0.018       -0.272   -0.520\*\*
  p value                       0.005        0.902        0.061    0
  NK2044 r                      -0.339\*     0.03         -0.243   -0.475\*\*
  p value                       0.019        0.839        0.096    0.001
  \*P \< 0.05, \*\*P \< 0.001                                      

###### Summary of correlation analysis of GC12 Vs GC3

                               GC12   AWD5 GC3    KP-1 GC3    Kp342 GC3   BA2146 GC3   NK2044 GC3
  ---------------------------- ------ ----------- ----------- ----------- ------------ ------------
  Drug resistance gene         r      0.478\*     0.454\*     0.305       0.440\*      0.429\*
                               p      0.018       0.026       0.138       0.031        0.037
  Infection related gene       r      0.038       -0.069      -0.009      0.222        -0.026
                               p      0.888       0.8         0.974       0.408        0.923
  Xenobiotic metabolism gene   r      0.478\*\*   0.482\*\*   0.483\*\*   0.499\*\*    0.503\*\*
                               p      0.001       0.001       0.001       0            0
  \*P\< 0.05, \*\*P \< 0.001                                                           

![Flowchart of the workflow](97320630016256F1){#F1}

![Phylogenetic tree constructed from the core genome of K. pneumoniae genomes. The scale bar, 0.01 corresponds to the substitution per amino acid within the coding regions of the core genome.](97320630016256F2){#F2}

![Core vs pan-genome development plot of K. pneumoniae genomes (EDGAR 2.2 software platform)](97320630016256F3){#F3}

![Dendogram showing the relationship between genomes based on the presence and absence of genes designated as group specific.](97320630016256F4){#F4}

![Cytoscape and GeneMANIA interaction network of known (a) clinical and (b) non-clinical unique core genes with co-expression and genetic interaction of other related genes. Nodes represent proteins and edges represent interactions between the nodes. Power law node-degree distribution of the networks in genes of clinical and non-clinical genomes (c and d). The node degree (k) is represented on the x-axis and number of nodes with a particular k is represented on the y-axis. The Pearson correlation coefficient values (r2) and the probability of degree distributions P(k) are shown. The red lines indicate the power law. The R-squared is computed on log values.](97320630016256F5){#F5}

![Visualizing common gene pools in five K. pneumoniae strains by Venn diagrams (EDGAR 2.2 software platform).](97320630016256F6){#F6}

![Neutrality plot of infection-related genes, drug resistance gene and xenobiotic metabolism genes of K. pneumoniae genome AWD5 (a-c), KP-1 (d-f), Kp342 (g-i), BA2146 (j-l), NK2044 (m-o). Individual genes are plotted based on the mean GC content in the first and second codon position (GC12) versus GC content of the third codon position (GC3).](97320630016256F7){#F7}
